AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇰🇪
Brolucizumab in Kenya
1 product registered with PPB — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Pagenax Solution for injection 120 mg/ml Solution For Injection | H2022/CTD10072/20966 | Novartis Overseas Investments AG | active | 26 Sept 2028 |
Brolucizumab — PPB Registration Details
PPB (Kenya) has 1 registered product containing Brolucizumab, of which 1 is currently active. Data is sourced directly from the official PPB drug register and refreshed daily.
Track Brolucizumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.